Kun Chen

6PUBLICATIONS
12CO-AUTHORS
Industrial molecular engineering of nucleic acids and proteinsPredictive and prognostic markersWastewater treatment processesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 13, 2026
An AviTag/BirA Platform for IL7: Minimized Activity Loss over Random Biotinylation.

Jingjing Kuang, Yu An, Jianguo Zhu

|Jul 21, 2025
Comprehensive Pan-Cancer Analysis Identifies IGFL1 as an Oncogenic Biomarker and Immunotherapeutic Target with Experimental Validation in Bladder Cancer.

Zongjian Liang, Yu An, Jie He

|Oct 25, 2021
Rosiglitazone Suppresses Renal Crystal Deposition by Ameliorating Tubular Injury Resulted from Oxidative Stress and Inflammatory Response via Promoting the Nrf2/HO-1 Pathway and Shifting Macrophage Polarization.

Hongyan Lu, Xifeng Sun, Min Jia

|Aug 25, 2021
The state of the art of bispecific antibodies for treating human malignancies.

Shuhang Wang, Kun Chen, Qi Lei

|Nov 25, 2020
MiR-1224-5p Activates Autophagy, Cell Invasion and Inhibits Epithelial-to-Mesenchymal Transition in Osteosarcoma Cells by Directly Targeting PLK1 Through PI3K/AKT/mTOR Signaling Pathway.

Bicheng Jin, Dongfang Jin, Zhaozhen Zhuo

|Jun 19, 2019
Bloom Syndrome Protein Activates AKT and PRAS40 in Prostate Cancer Cells.

Kun Chen, Houqiang Xu, Jiafu Zhao

Pageof 1

Frequent Collaborators

1 joint publications

Houqiang Xu

1 joint publications

Qi Lei

1 joint publications

Andy Qingan Yuan

1 joint publications

Yingjie Nie